Technology is revolutionizing the world around us including creating new opportunities to deliver medical education and to provide clinical care globally. Artificial Intelligence (AI) has been amongst the most exciting advances in the last few years and now such work is being deployed globally.
This lecture will review how AI has been developed and approved specifically for diabetic retinopathy. This interactive webinar will also highlight the critical importance of the demonstrated safety, efficacy, and critical ethical reviews of such technology.
Lecturer: Dr. Michael Abramoff, MD, PhD, (FARVO) Professor of Ophthalmology and Visual Sciences, University of Iowa, USA
July 24, 2020